Progress in diagnosis and treatment of amniotic fluid embolism

doi:10.3969/j.issn.1004-583X.2016.04.006

Abstract

Abstract: Amniotic fluid embolism is a rare but dreadful obstetric complications with a high maternal mortality, which caused by the transfer of amniotic fluid substances into the maternal circulation. In order to reduce the mortality, it is necessary to be familiar with the pathogenesis and clinical manifestations, and then make early diagnosis and choose the effective treatment.

Key words: embolism,amniotic fluid, risk factors, pathogenesis, diagnosis, therapy

CLC Number:

R714.468

Zhang Yangyang, Yuan Yadong. Progress in diagnosis and treatment of amniotic fluid embolism[J]. Clinical Focus, 2016, 31(4): 368-372.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2016.04.006

https://huicui.hebmu.edu.cn/EN/Y2016/V31/I4/368

References

[1] Meyer JR. Embolia pulmonary amnio caseosa[J]. Br Med,1926,2:301-303.
[2] Steiner PE,Lushbaugh CC. Landmark article, Oct. 1941: Maternal pulmonary embolism by amniotic fluid as a cause of obstetric shock and unexpected deaths in obstetrics[J]. JAMA,1986,255(16):2187-2203.
[3] 乐杰.妇产科学[M].7版.北京: 人民卫生出版社,2008:208-210.
[4] Busardo FP,Gulino M,Di Luca NM,et al. Not only a clinical nightmare: amniotic fluid embolism in court[J].Curr Pharm Biotechnol,2014,14(14):1195-1200.
[5] Mo X,Feng A,Liu X,et al. Amniotic Fluid Embolism (AFE) in China: are maternal mortality and morbidity preventable [J]. Intractable Rare Dis Res,2014,3(3):97-99.
[6] Knight M,Berg C,Brocklehurst P,et al. Amniotic fluid embolism incidence, risk factors and outcomes: review and recommendations [J]. BMC Pregnancy Childbirth,2012,12(3):7-17.
[7] 中华人民共和国卫生和计划生育员会. 2013年中国卫生和计划生育统计年鉴[M].2版.北京: 中国协和医科大学出版社,2014: 78-80.
[8] Kramer MS,Rouleau J,Baskett TF,et al. Amniotic fluid embolism and medical induction of labour: a retrospective, population-based cohort study [J]. Lancet,2006,368(9545):1444-1448.
[9] Kramer MS,Rouleau J,Liu S,et al. Amniotic fluid embolism: incidence, risk factors, and impact on perinatal outcome [J]. BJOG,2012,119(7):874-879.
[10] Kramer MS,Abenhaim H,Dahhou M, et al. Incidence, risk factors, and consequences of amniotic fluid embolism [J].Paediatr Perinat Ep,2013,27(5):436-441.
[11] Abenhaim HA,Azoulay L,Kramer MS,et al. Incidence and risk factors of amniotic fluid embolisms: a population-based study on 3 million births in the United States [J]. Am J Obstet Gynecol,2008,199(1):49,e1-8.
[12] Knight M,Tuffnell D,Brocklehurst P,et al. Incidence and risk factors for amniotic-fluid embolism [J].Obstet Gynecol,2010,115(5):910-917.
[13] Roberts CL,AlgertCS,KnightM,et al. Amniotic fluid embolism in an Australian population-based cohort [J]. BJOG,2010,117(11):1417-1421.
[14] Fitzpatrick KE, Tuffnell D, Kurinczuk JJ,et al. Incidence, risk factors, management and outcomes of amniotic-fluid embolism: a population-based cohort and nested case-control study [J]. BJOG,2016,123(1):100-109.
[15] Masson RG,Ruggieri J,Siddiqui MM. Amniotic fluid embolism: definitive diagnosis in a survivor [J]. Am Rev Respir Dis,1979,120(1):187-192.
[16] Talbert LM,Adcock DF,Weiss AE,et al. Studies on the pathogenesis of clotting defects during salt induced abortions[J]. Am J Obstet Gynecol,1973,115(5):656-662.
[17] Benson MD. A hypothesis regarding complement activation and amniotic fluid embolism[J]. Medical Hypotheses,2007,68(5):1019-1025.
[18] Chen KB,Chang SS,Tseng YL,et al. Amniotic fluid induces platelet-neutrophil aggregation and neutrophil activation[J]. AJOG,2013,208(4):318,e1-7.
[19] Attwood HD. Fatal pulmonary emboliom by amniotic fluid[J]. J Clin Pathol,1956,9(1):35-46.
[20] Clark SL,HankinsGD,Dudley DA,et al.Amniotic fluid embolism: Analysis of the national registry[J]. Am J Obstet Gynecol,1995,172(4):1158-1167.
[21] Benson MD. Anaphylactoid syndrome of pregnancy[J].Am J Obstet Gynecol,1996,175(3):749.
[22] Benson MD,lindberq RE. Amniotic fluid embolism, anaphylaxis, and tryptase[J].Am J Obstet Gynecol,1996,175(3):737.
[23] Benson MD,Kobayashi H,Silver RK,et al. Immunologic studies in presumed amniotic fluid embolism[J]. Obstet Gynecol,2001,97(4):510-514.
[24] Benson MD. Current concepts of immunology and diagnosis in amniotic fluid embolism[J].Clin Dev Immunol,2012,doi:10.1155/2012/946576.
[25] Tamura N,Kimura S,Farhana M,et al. C1 esterase inhibitor activity in amniotic fluid embolism[J]. Crit Care Med,2014,42(6):1392-1396.
[26] Chen KB,Chang SS,Tseng YL,et al. Amniotic fluid induces platelet neutrophil aggregation and neutrophil activation[J]. Am J Obstet Gynecol,2013,208(4):318-327.
[27] Conde-Agudelo A,Romero R.Amniotic fluid embolism: an evidence-based review[J].Am J Obstet Gynecol,2009,201(5):445,e1-13.
[28] Finesenhi V,Gambassi R,Gherardi M,et al. The diagnosis of amniotic fluid embolism: an immunohistochemical study for the quantification of pulmonary mast cell tryptase[J].Int J Legal Med,1998,111(5):238-243.
[29] Manchanda R,Sriemevan A. Anaphylactoid syndrome caused by amniotic fluid embolism following manual removal of placenta[J]. J Obstet Gynaecol,2005,25(2):201-202.
[30] James CF,Feinglass NG,Menke DM,et al. Massive amniotic fluid embolism: diagnosis aided by emergency transesophageal echocardiography[J]. Int J Obstet Anesth,2004,13(4):279-283.
[31] Saad A,El-Husseini N,Nader GA,et al. Echocardiographically detected mass “intransit” in early amniotic fluid embolism[J].Eur J Echocardiogr,2006,7(4):332-335.
[32] Resnik R,Swartz WH,Plumer MH,et al. Amniotic fluid embolism with survival[J].Obstet Gynecol,1976,47(3):295-298.
[33] Kuhlman K,Hidvegi D,Tamura RK, et al. Is amniotic fluid material in the central circulation of peripartum patients pathologic [J].Am J Perinatol,1985,2(4):295-299.
[34] Clark SL,Pavlova Z,Greenspoon J,et al. Squamous cells in the maternal pulmonary circulation[J]. Am J Obstet Gynecol,1986,154(1):104-106.
[35] Lee W,Ginsburg KA,Cotton DB,et al. Squamous and trophoblastic cells in the maternal pulmonary circulation identified by invasive hemodynamic monitoring during the peripartum period[J]. Am J Obstet Gynecol,1986,155(5):999-1001.
[36] Kanayama N,Yamazaki T,Naruse H,et al. Determining zinc coproporphyrin in maternal plasma--a new method for diagnosing amniotic fluid embolism[J].Clin Chem,1992,38(4):526-529.
[37] Oi H,Kobayashi H,Hirashima Y,et al. Serological and immunohistochemical diagnosis of amniotic fluid embolism[J].SeminThromb Hemost,1998,24(5):479-484.
[38] Kobayashi H,Ohi H,Terao T. A simple, noninvasive, sensitive method for diagnosis of amniotic fluid embolism by monoclonal antibody TKH-2 that recognizes NeuAc alpha 2-6GalNAc[J]. Am J Obstet Gynecol,1993,168(3):848-853.
[39] Stawicki SP,Papadimos TJ. Challenges in managing amniotic fluid embolism: an up-to-date perspective on diagnostic testing with focus on novel biomarkers and avenues for future research[J]. Curr Pharm Biotechnol,2014,14(14):1168-1178.
[40] Sinicina I,Pankratz H,Bise K,et al. Forensic aspects of post-mortem histological detection of amniotic fluid embolism[J].Int J Legal Med,2010,124(1):55-62.
[41] Leighton BL, Wall MH, Lockhart EM, et al. Use of recombinant factor VIIa inpatients with amniotic fluid embolism: a systematic review of case reports[J].Anesthesiology,2011,115(6):1201-1208.
[42] Kanayama N, Tamura N. Amniotic fluid embolism: pathophysiology and new strategies for management[J]. J Obstet Gynaecol Res,2014,40(6):1507-1517.
[43] Tuffnell DJ. United Kingdom amniotic fluid embolism register[J]. BJOG,2005, 112(12):1625-1629.